Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients
Author:
Affiliation:
1. Department of Dermatology; Bispebjerg Hospital; Copenhagen Denmark
2. Center for Medical Research Methodology; Department of Biomedical Sciences; University of Copenhagen; Copenhagen Denmark
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14540/fullpdf
Reference16 articles.
1. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis;Hijnen;J Eur Acad Dermatol Venereol,2007
2. TNF-alpha inhibitors for chronic urticaria: experience in 20 patients;Sand;J Allergy,2013
3. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients;Sand;Dermatol Ther,2015
4. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria;Maurer;N Engl J Med,2013
5. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy;Kaplan;J Allergy Clin Immunol,2013
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New insights into chronic inducible urticaria;Current Allergy and Asthma Reports;2024-07-19
2. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria;International Archives of Allergy and Immunology;2024-06-18
3. Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis;World Allergy Organization Journal;2024-04
4. An update on the use of antihistamines in managing chronic urticaria;Expert Opinion on Pharmacotherapy;2024-03-23
5. Predictive value of the systemic immune inflammation index and systemic inflammatory response index on omalizumab drug survival in chronic spontaneous urticaria;Allergo Journal International;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3